Trial Profile
Effects of Esomeprazole Magnesium on Gastric Free Radical Production and Total Antioxidant Capacity in Dyspeptic Patients Receiving Non-Steroidal Anti-Inflammatory Drugs
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 25 Aug 2020
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary) ; Ranitidine
- Indications Dyspepsia
- Focus Therapeutic Use
- 19 Aug 2020 Status changed from discontinued to withdrawn prior to enrolment as the study was not approved by the Human Studies Subcommittee.
- 20 Dec 2007 Status changed from recruiting to discontinued. The Principal Investigator is no longer affiliated with the Study Site.
- 30 Apr 2007 New trial record.